معرفی
Antonio Giordano is a Professor in the Department of Biology at Temple University and Director of the Sbarro Institute for Cancer Research and Molecular Medicine. He also holds the 'chiara fama' Professorship in Anatomic Pathology at the University of Siena, Italy. His research focuses on cancer development mechanisms, particularly cell cycle regulation via tumor suppressor genes like RBL2/p130, CDK9/10, and p27. With over 600 publications, he leads interdisciplinary cancer research spanning molecular biology, translational medicine, and clinical applications. Giordano mentors over 200 researchers globally and chairs the Sbarro Health Research Organization (S.H.R.O.), dedicated to chronic disease research. His work integrates biotechnology innovations with oncology, including liquid biopsy technologies and ADC drug development.
Education: Not explicitly listed, but his dual professorships imply advanced degrees in Molecular Biology/Pathology. Research Interests: Cancer biology, cell cycle regulation, tumor suppressors, and translational cancer therapies. Key Projects: Sbarro Institute initiatives, Phase I/II clinical trials for novel cancer drugs, and international collaborations in oncology. Labs/Teams: Sbarro Institute for Cancer Research, Center for Biotechnology (Temple University).
Grants/Advising: Extensive grant reviews and mentorship of postdocs. Awards: Not explicitly listed but implied by his academic and leadership roles.
